Sildenafil citrate by XOMA Royalty for Female Hypoactive Sexual Desire Disorder: Likelihood of Approval
Sildenafil citrate is under clinical development by XOMA Royalty and currently in Phase II for Female Hypoactive Sexual Desire Disorder.
Sildenafil citrate is under clinical development by XOMA Royalty and currently in Phase II for Female Hypoactive Sexual Desire Disorder.
What's Your Reaction?
